This study investigated the clinicopathological characteristics of mucinous gastric carcinoma (MGC) and assessed whether multidetector-row computed tomography (MDCT) could differentiate MGC from non-mucinous gastric carcinoma (NGC). Clinicopathological data from 542 patients with gastric carcinoma (23 MGC, 519 NGC), who underwent pre-operative MDCT examination and curative or palliative gastrectomy, were analysed. Only seven of the 23 patients with MGC were correctly diagnosed pre-operatively by endoscopic biopsy. The MGC patients had larger tumours, a higher frequency of lymph node metastases, were more likely to have tumours of tumour, node, metastasis stages III and IV, and were less likely to have a curative resection than NGC patients. In addition, five MGC patients had calcifications in the thickened gastric wall. In conclusion, MGC is rare and is detected mostly at an advanced stage. The diagnostic sensitivity of MGC by endoscopic biopsy was relatively low, whereas MDCT was helpful in distinguishing MGC from NGC. KEY WORDS: STOMACH NEOPLASMS; ADENOCARCINOMA; MUCUS; MULTIDETECTOR-ROW COMPUTED TOMOGRAPHY; COMPARATIVE STUDY C Yan, Z-G Zhu, M Yan et al. Mucinous gastric carcinoma characteristics of MGC and to evaluate the capability of multidetector-row CT (MDCT) to assist in the differentiation between MGC and NGC, with a focus on the thickened stomach wall itself.
Introduction
Mucinous gastric carcinoma (MGC) is a very rarely found (2.4 -4.9%) histological type of gastric carcinoma. 1 There are few published reports about MGC and little is clear about its clinicopathological characteristics and prognosis. The results of some studies 2 − 6 indicate that the overall survival rate for patients with MGC is worse than that for patients with non-mucinous gastric carcinoma (NGC). MGC was often found to be highly invasive at initial diagnosis, highlighting the importance of distinguishing MGC from NGC preoperatively. A previous report showed, however, that the diagnostic sensitivity of endoscopic biopsy for MGC was only 33.3% (two of six cases). 7 A study by Park et al. 8 indicated that computed tomography (CT) with adequate water distension of the stomach might help to distinguish MGC from NGC, primarily on the basis of the enhancement pattern, the predominant layer of thickened wall and the gross appearance.
The aim of the present study was to investigate the clinicopathological
Patients and methods

PATIENTS AND INCLUSION CRITERIA
This study evaluated clinicopathological data from patients with gastric carcinoma, referred for MDCT examination for pre-operative staging, who subsequently underwent curative or palliative gastrectomy in the Third Department of General Surgery of the Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China, between October 2000 and April 2007. None of the patients underwent any preoperative radiotherapy or chemotherapy. All patients underwent MDCT examination pre-operatively with the triphasic scan technique, similar to methods previously reported. 9 − 11 As all MGC patients had advanced-stage disease, only advancedstage NGC patients were selected as controls for investigation of MDCT features. Patients with advanced NGC were systemically sorted, first by their medical record numbers, and then every 10th patient was designated as a control case. To test whether the selected control cases provided valid representatives of the entire advanced-stage NGC population, an analysis was performed between the selected cases and the entire NGC group on the basis of their clinicopathological data. Subsequently, no significant differences were found between the two groups in terms of age, gender, tumour location, tumour size, depth of invasion, lymph node metastasis, distant metastasis, and tumour, node, metastasis (TNM) stage.
Verbal informed consent was obtained from all patients for participation in this study. As pre-operative MDCT is a routine examination at Ruijin Hospital, ethical approval of the study protocol was not required.
DIAGNOSTIC CRITERIA
Mucinous gastric carcinoma was defined as a tumour in which more than one-half of the tumour area contained extracellular mucin pools. 12 Pathological tumour staging was based on the International Union Against Cancer TNM classification. 13 The axial CT image with the maximum diameter was subjectively selected for analysis of the enhancement pattern, the gross appearance type, the maximum diameter and the tumour thickness (which was measured at the central part of the thickened wall). The Borrmann classification 14 of advanced gastric carcinoma was applied to adjust for the gross appearance of tumours. Borrmann type I tumours are polypoid or fungating lesions, type II are ulcerating lesions surrounded by elevated borders, type III are ulcerating lesions with infiltration into the gastric wall and type IV are diffusely infiltrating lesions. The contrastenhancement patterns were estimated according to the axial CT images obtained during the equilibrium phase and were classified as: (A) homogeneous; (B) heterogeneous; or (C) layered (two-to threelayered structures). In the cases of a layered pattern, the ratio of high-attenuating innerlayer thickness to total thickness was further calculated. Other associated findings, such as tumour calcifications, were also evaluated.
STATISTICAL ANALYSES
Statistical analyses were carried out using the SPSS ® statistical package, version 10.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Quantitative data were presented as mean ± 
Results
PATIENTS
Clinicopathological data from 542 patients with gastric carcinoma (353 men and 189 women) were included in the study ( Table 1 ). The age range of patients was 22 -87 years (mean 58 years). Overall, 92 patients had early gastric carcinoma and 450 had advanced gastric carcinoma. There were 23 patients with MGC all with advanced stage disease (4.24% of all gastric carcinomas) and 519 with NGC.
CLINICOPATHOLOGICAL
CHARACTERISTICS OF MGC COMPARED WITH NGC
Only seven of the 23 cases (30.4%) of MGC were correctly diagnosed pre-operatively by endoscopic biopsy; the remaining 16 MGC tumours were misdiagnosed as NGC tumours. All 23 MGC patients had advanced-stage disease. In contrast, 17.7% (92/519) of the NGC were early gastric carcinoma cases, which was a significant difference between the two groups (P = 0.021). Compared with NGC patients, MGC patients were found to have larger tumours (P = 0.003), a greater incidence of tumours that invaded more deeply (P = 0.021), a higher frequency of lymph node metastases (87.0% versus 60.0%, P = 0.009), were more likely to have tumours of TNM stages III and IV (78.3% versus 55.1%, P = 0.029), and were less likely to have curative resections (73.9% versus 88.6%, P = 0.046). No significant differences were seen between the MGC and NGC patients in age, gender, tumour location and distant metastasis ( Table 1) .
CT FEATURES OF MGC COMPARED WITH NGC
For investigation of MDCT features the 23 MGC patients with advanced-stage disease were compared with 43 NGC patients with advanced-stage disease who were selected as controls, as described in the Patients and Methods section. On the axial CT images, compared with NGC, MGC tumours were of a larger diameter (7.28 ± 3.55 cm versus 5.23 ± 1.78 cm, P = 0.015), were thicker (1.98 ± 0.79 cm versus 1.34 ± 0.50 cm, P < 0.001) and had a higher frequency of Borrmann types III and IV (69.6% versus 41.9%, P = 0.032); features are summarized in Table 2 . The most common contrast-enhancement pattern in MGC tumours was the layered type (n = 15, 65.2%), whereas the most common pattern in NGC tumours was the homogeneous type (n = 30, 69.8%). In tumours with a layered contrastenhancement pattern, the ratio of highattenuating inner-layer thickness to total thickness was significantly lower in MGC compared with NGC tumours (P < 0.001; Table 2 , Figs 1 and 2).
Five patients with MGC had miliary punctuate calcifications in their tumours. Among these tumours with calcifications, there were four cases with a layered enhancement pattern and their diffusely miliary calcifications were located in the obviously thickened low-attenuating middle layer, which corresponded to the mucin pool (Fig. 1C ). In addition, there was one case with a heterogeneous enhancement pattern and only a few punctate calcifications. No calcifications were seen in any patients with NGC.
Discussion
Although gastric carcinoma is one of the most important causes of death from malignant disease worldwide, 15 the C Yan, Z-G Zhu, M Yan et al.
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histological classification of gastric carcinoma remains controversial. The most common systems in use include the World Health Organization (WHO), the Lauren, and the Ming classifications. 16 No one system is ideal, in part because many tumours are not uniform and show considerable overlap of histological patterns. MGC is a rare histological entity and early MGC is extremely rarely identified: the reported incidence of MGC among all gastric carcinomas is 2.4 -4.9%, 1 whereas the incidence of early MGC is 0.2 -0.5%. 17 The clinicopathological features and prognosis of MGC have not yet been fully clarified.
In the present study, 23 MGC patients were investigated and it was demonstrated that the incidence of MGC was 4.24% of all cases of gastric carcinomas. Compared with NGC, the MGC patients were found to have larger tumours, a greater incidence of tumours that had invaded more deeply, a higher frequency of lymph node metastases, a lower frequency of curative resections and tumours that were more likely to be classified as TNM stages III and IV, consistent with 2 reported that MGC patients had a lower frequency of curative resection than NGC patients, whereas other reports showed no significant differences between the two groups. 3, 12 Kawamura et al. 1 also reported that MGC patients had a higher frequency of peritoneal metastasis than NGC patients, whereas the results of Woo et al. 2 showed no significant difference between MGC and NGC, in this measure. Peritoneal metastasis was not included in the present investigation because of the small sample size. The present study showed, however, that there was no significant difference between MGC and NGC patients in the incidence of distant metastasis. The differences between study findings may be due to variations in sample size and regional variations.
A prognostic analysis was not included in the present study. This is in contrast to previous reports, which showed that MGC patients had poorer prognoses than NGC patients due to the advanced stage of the MGC at diagnosis, the higher frequency of lymph node metastasis and higher TNM status. 1 -3,12 Despite curative resection, a large proportion of patients with locally advanced gastric cancer will experience a recurrence. 18 To improve the prognosis of these patients, pre-operative therapeutic modalities (neoadjuvant therapies) are currently being investigated, and initial published results are promising. 18, 19 After these advances have been confirmed, more precise pre-operative diagnostic imaging will be required.
In the 2010 National Comprehensive Cancer Network clinical practice guidelines for gastric carcinoma, gastric carcinoma patients (M0) with clinical stage T2 or higher, or N + , are recommended to undergo surgery or neoadjuvant therapy. 20 According to these criteria, most MGC patients in the present study -except for patients with stage M1 -would be fit to undergo neoadjuvant therapy. Thus, MGC may become one of the selection criteria for neoadjuvant therapy for gastric carcinoma because of its clinicopathological characteristics. In addition, MGC patients tend to have higher rates of peritoneal metastasis than NGC patients, 1 so MGC may become one of the selection criteria for staging laparoscopy for the diagnosis of peritoneal metastasis, and to avoid unnecessary laparotomies.
Research indicates that combined positron emission tomography (PET)-CT imaging has many advantages over PET or CT alone, as it significantly improved diagnostic accuracy and pre-operative staging of tumours. 21 However, MGC displays consistently low detection rates using PET; 22 thus, PET seems to have little or no value in the primary detection and pre-operative staging of MGC patients specifically, and PET-CT may also be unnecessary in these patients. Clearly, research indicates that it is very important to distinguish MGC from NGC pre-operatively.
The diagnostic sensitivity of MGC using endoscopic biopsy has been reported to be relatively low (30%). 7 In a study by Flucke et al., 23 although the diagnostic sensitivity of MGC was not calculated, only 84% of cases showed the same growth pattern in preoperative biopsies as in resected tumour specimens, according to the WHO histological classification. A study by Park et al. 8 indicated that MDCT with adequate distension of the stomach by water might help to distinguish MGC from NGC. Moreover, because MDCT is a promising technique for the detection and pre-operative staging of gastric carcinoma, 24 − 28 the clinical value of investigating the usefulness of CT in distinguishing MGC from NGC becomes higher.
In the study by Park et al. 8 patients with signet ring cell carcinoma were excluded from analysis of the CT features of MGC and NGC. Lee et al. 29 found that MDCT could not help to distinguish advanced gastric carcinoma with signet ring cell carcinoma from non-signet ring cell carcinoma. Thus, advanced signet ring cell carcinomas were not excluded in the present study.
The MGC patients in the present study were found to have larger tumours on axial CT images than the NGC patients, and this result was concordant with that of the clinicopathological study. In addition, the MGC tumours were thicker than NGC tumours, which may be related to the fact that the MGC patients had a greater frequency of Borrmann type III and IV tumours than NGC patients. In contrast, Park et al. 8 reported no significant difference between MGC and NGC in tumour thickness.
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It is presumed that this discrepancy may result from the different methods used to measure tumour thickness in both studies. The axial CT image with the maximum diameter was subjectively selected in the present study, and the thickness of the tumour at the central part of the thickened gastric wall was then measured. In contrast, Park et al. 8 measured the tumour at the thickest point of the most thickened wall, so the thickness of the ulcerative gastric carcinoma might have been measured at the elevated edges.
On the axial CT images, patients with MCG in the present study had a higher frequency of Borrmann type III and IV tumours than NGC patients (69.6% versus 41.9%). The Borrmann classification of advanced gastric carcinoma was not included in the present clinicopathological study, because detailed records about the gross appearance of tumours were lacking in some patients. The clinicopathological study by Shibuya et al. 30 showed that the frequency of Borrmann type III and IV tumours in MGC and NGC patients was 60% and 36%, respectively; these results were consistent with the present study. Park et al. 8 classified the gross appearance of gastric carcinoma into four types: polypoid; fungating; ulcerated; and diffusely infiltrative. They showed that the most common type of gross appearance in both carcinomas was fungating, with the next most common being ulcerated in NGC and diffusely infiltrative in MGC. Their findings were concordant with the present study.
The most common contrastenhancement pattern in MGC patients in the present study was of the layered type, whereas the most common pattern in NGC patients was the homogeneous type. In patients with a layered contrastenhancement pattern, the ratio of high-attenuating inner layer thickness to total thickness was significantly lower in the MGC patients compared with that in NGC patients. These results are consistent with those of Park et al., 8 although they evaluated the enhancement pattern according to the parenchymal-phase images. Rossi et al. 31 reported that a low-density band existed in most lesions of diffuse gastric carcinomas (Lauren classification) on the parenchymalphase CT images. Thus, there was a discrepancy between these two studies about the enhancement pattern of gastric carcinoma on the parenchymal-phase CT image. Furthermore, a study by Takao et al. 9 showed that, when tumour-wall thickening was prominent, advanced gastric carcinomas showed gradual enhancement from the inner-mucosal side to the outerserosal side of the tumour and enhancement of the entire tumour in the equilibrium phase.
The gradual-enhancement characteristics of advanced gastric carcinoma were also found in some NGC patients in the present study. Thus, we believe that reliability of the equilibriumphase CT images in the differentiation between MGC and NGC is higher. In addition, the axial CT image with the maximum diameter should be subjectively selected for precise evaluation of the enhancement pattern of gastric carcinoma, because a peri-tumour low-density band exists in most gastric carcinomas (see Figs 2A  and 2B) .
The enhancement pattern and the most thickened layer differed between MGC and NGC patients in the present study. These findings corresponded closely to the histopathological composition of the tumours. A thickening of the diffusely lowattenuating middle or outer layers on the CT images of MGC tumours with a layeredenhancement pattern corresponded to the • Received for publication 6 September 2010 • Accepted subject to revision 9 September 2010
• Revised accepted 1 December 2010 Copyright © 2011 Field House Publishing LLP mucin pools located primarily in the submucosa or deeper layer in pathological specimens, while the enhancing portion of the MGC was either the overlying normal mucosa or columns of malignant cells. The most common enhancement pattern of the NGC was the homogeneous type and the attenuation was high, reflecting the enhancement of the malignant cell group, which was located within the entire wall without layering. Aside from the nonmucinous carcinomas with these characteristics, most of the remaining nonmucinous tumours showed a thickening of the inner layer, which corresponded to malignant cell groups located primarily in the mucosal layer and extending into the deeper layer. 8 There were five MGC patients with miliary punctuate calcifications in their tumours in the present study, whereas no calcifications were seen in any of the patients with NGC. Calcification of gastric carcinoma is extremely rare, and all reported cases correspond to a mucinous adenocarcinoma. 32 Calcifications are one of the characteristic findings of MGC, 33 although the pathogenesis of calcification within MGC is undetermined. The most likely theory is that the mucin is a glycoprotein very similar to that present in the cartilage of the provisional zone of calcification and has, therefore, a great propensity to calcify. The calcifications in MGC are described as being nodular, miliary, punctuate and homogeneously distributed within the mucin pools of the thickened gastric wall, and the size of calcifications is usually described as being 1 -3 mm. 34 Leiomyomas and leiomyosarcomas sometimes contain calcifications, but these are usually circumscribed and patchy. 35 The dystrophic calcifications of gastric carcinoma after chemotherapy (calcification in ischaemic and necrotic areas) are conglomerate. 36 Thus, miliary and punctuate calcifications within the gastric carcinoma are thought to be characteristic and diagnostic of MGC.
In conclusion, the present study demonstrated that MGC is rare and detected mostly in an advanced stage. Furthermore, patients with MGC had larger tumours, a higher frequency of lymph node metastases, greater frequency of TNM stages III and IV, and a lower frequency of curative resection compared with patients with NGC tumours. The diagnostic sensitivity of MGC by using endoscopic biopsy was relatively low. MDCT was, however, helpful in distinguishing MGC from NGC when the size, thickness, gross appearance, enhancement pattern and calcifications of tumours on axial images were systematically analysed.
